Fingolimod for the treatment of remitting multiple sclerosis: experience of the Moscow Multiple Sclerosis Center (MMSC)

13 patients from the Moscow Multiple Sclerosis Center with remitting MS and not responsive to treatment with 1st line DMD were given Fingolimod (Gilenya) starting from January 2012. After one year of therapy, the group demonstrated a significant decrease in the frequency of exacerbations from 2,54 ±...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. V. Popova, A. A. Yalymov, A. N. Boyko, M. V. Davydovskaya, E. V. Kolyak, O. V. Traktirskaya, N. V. Khachanova, S. G. Schur
Formato:	Artigo
Idioma:	Russo
Publicado em:	Remedium Group LLC 2014-12-01
coleção:	Медицинский совет
Assuntos:	ремитирующий рассеянный склероз препараты изменяющие течение рассеянного склероза финголимод суточное мониторирование экг remitting multiple sclerosis multiple sclerosis disease modifying drugs fingolimod holter ecg monitoring
Acesso em linha:	https://www.med-sovet.pro/jour/article/view/569
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!